Exane Derivatives’s Nordstrom JWN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$148 Hold
7
﹤0.01% 700
2022
Q1
$190 Hold
7
﹤0.01% 964
2021
Q4
$158 Sell
7
-121
-95% -$3.21K ﹤0.01% 850
2021
Q3
$3.38K Hold
128
﹤0.01% 761
2021
Q2
$4.46K Hold
128
﹤0.01% 781
2021
Q1
$4.85K Hold
128
﹤0.01% 622
2020
Q4
$4K Sell
128
-28
-18% -$585 ﹤0.01% 572
2020
Q3
$1.86K Sell
156
-2,411
-94% -$36.1K ﹤0.01% 567
2020
Q2
$39.8K Buy
2,567
+2,526
+6,161% +$44.5K 0.01% 371
2020
Q1
$629 Hold
41
﹤0.01% 570
2019
Q4
$1.66K Hold
41
﹤0.01% 515
2019
Q3
$1.38K Hold
41
﹤0.01% 520
2019
Q2
$1.31K Hold
41
﹤0.01% 543
2019
Q1
$1.82K Hold
41
﹤0.01% 457
2018
Q4
$1.91K Hold
41
﹤0.01% 527
2018
Q3
$2.45K Sell
41
-549
-93% -$31.4K ﹤0.01% 485
2018
Q2
$30.9K Sell
590
-43,793
-99% -$2.17M 0.01% 409
2018
Q1
$2.13M Buy
44,383
+44,348
+126,709% +$2.21M 0.43% 60
2017
Q4
$1.66K Sell
35
-1,929
-98% -$83.1K ﹤0.01% 472
2017
Q3
$92.6K Sell
1,964
-1,418
-42% -$65.8K 0.02% 273
2017
Q2
$162K Buy
+3,382
New +$154K 0.03% 215

Other funds holding JWN

Exane Derivatives's JWN Position: Q2 2022 in Review

Exane Derivatives held its Nordstrom (JWN) position steady in Q2 2022 at 7 shares worth $148. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Exane Derivatives first reported a position in JWN in Q2 2017 and has held it in 21 quarters since. The position peaked at $2.13M in Q1 2018. 378 funds tracked by Wall St. Rank hold JWN as of Q2 2022.

  • Exane Derivatives held 7 shares of Nordstrom worth $148 as of Q2 2022.
  • Exane Derivatives left its Nordstrom share count unchanged in Q2 2022.
  • Nordstrom made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #700 holding.
  • Exane Derivatives first reported a position in Nordstrom in Q2 2017 and has held it in 21 quarters since.
  • Exane Derivatives's Nordstrom position peaked at $2.13M in Q1 2018.
  • 378 funds tracked by Wall St. Rank held Nordstrom as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.